86
Views
1
CrossRef citations to date
0
Altmetric
Review

Association of Cardiovascular Risk Assessment with Early Colorectal Neoplasia Detection in Asymptomatic Population: A Systematic Review and Meta-Analysis

, ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 865-873 | Published online: 11 Aug 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:doi:10.3322/caac.2149230207593
  • Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–694. doi:doi:10.1161/CIRCRESAHA.117.30890328860318
  • Chan AOO, Man HJ, Kwok FL, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. J Am Med Assoc. 2007;298(12):1412. doi:doi:10.1001/jama.298.12.1412
  • Chan AOO, Lam KF, Tong T, et al. Coexistence between colorectal cancer/adenoma and coronary artery disease: results from 1382 patients. Aliment Pharmacol Ther. 2006;24(3):535–539. doi:doi:10.1111/j.1365-2036.2006.02958.x16886920
  • Wang SC, Schulman-Marcus J, Fantauzzi J, et al. Colon cancer laterality is associated with atherosclerosis and coronary artery disease. J Gastrointest Oncol. 2019. doi:doi:10.21037/jgo.2018.09.18
  • Kahr PC, Hammerl S, Huber-Schönauer U, et al. Atrial fibrillation: a new indicator for advanced colorectal neoplasia in screening colonoscopy. J Clin Med. 2019;8(7):1083. doi:doi:10.3390/jcm8071083
  • Masoudkabir F, Sarrafzadegan N, Krahn A, et al. Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention HHS Public Access. Atherosclerosis. 2017;263:343–351. doi:doi:10.1016/j.atherosclerosis.2017.06.00128624099
  • Piepoli MF, Hoes AW, Agewall S, et al. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;2016(252):207–274. doi:doi:10.1016/j.atherosclerosis.2016.05.037
  • Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. doi:doi:10.1161/CIR.000000000000067830879355
  • Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188. doi:doi:10.1093/eurheartj/ehz45531504418
  • Grundy SM, Becker D, Clark LT, et al. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2002;106(25):3143–3421. doi:doi:10.1161/circ.106.25.314312485966
  • Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc. 2001;285(19):2486–2497. doi:doi:10.1001/jama.285.19.2486
  • Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310–315. doi:doi:10.1161/hc0302.10257511804985
  • Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 PART B):2935–2959. doi:doi:10.1016/j.jacc.2013.11.00524239921
  • Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with framingham risk score to predict. JAMA. 2015;300(2):197–208.
  • Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals. J Am Med Assoc. 2004;291(2):210–215. doi:doi:10.1001/jama.291.2.210
  • Polak JF, Szklo M, Kronmal RA, et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2(2):2. doi:doi:10.1161/JAHA.113.000087
  • Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98(12):2648–2654. doi:doi:10.1016/j.amjgastroenterol.2003.09.04114687811
  • Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology. 2006;131(4):1011–1019. doi:doi:10.1053/j.gastro.2006.08.01517030171
  • Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: A validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236–1241. doi:doi:10.1136/gut.2010.22116821402615
  • Schroy PC, Wong JB, O’Brien MJ, Chen CA, Griffith JL. A risk prediction index for advanced colorectal neoplasia at screening colonoscopy. Am J Gastroenterol. 2015;110(7):1062–1071. doi:doi:10.1038/ajg.2015.14626010311
  • Kim DH, Cha JM, Shin HP, Joo KR, Lee J, Park D. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in korea. J Clin Gastroenterol. 2015;49(1):41–49. doi:doi:10.1097/MCG.000000000000010224583751
  • Chen G, Mao B, Pan Q, Liu Q, Xu X, Ning Y. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chinese J Cancer Res. 2014;26(1):4–11. doi:doi:10.3978/j.issn.1000-9604.2014.02.03
  • Cai QC, Da YE, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk chinese. Am J Epidemiol. 2012;175(6):584–593. doi:doi:10.1093/aje/kwr33722328705
  • Ulmer H, Borena W, Rapp K, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer. 2009;101(7):1202–1206. doi:doi:10.1038/sj.bjc.660526419690552
  • Chandler PD, Song Y, Lin J, et al. Lipid biomarkers and long-term risk of cancer in the Women’s Health Study. Am J Clin Nutr. 2016;103(6):1397–1407. doi:doi:10.3945/ajcn.115.12432127099252
  • Peng L, Weigl K, Boakye D, Brenner H. Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis. Am J Gastroenterol. 2018;113(12):1788–1800. doi:doi:10.1038/s41395-018-0209-230315282
  • Basyigit S, Ozkan S, Uzman M, et al. Should screening for colorectal neoplasm be recommended in patients at high risk for coronary heart disease. Med (United States). 2015;94:20. doi:doi:10.1097/MD.0000000000000793
  • Yamaji Y, Mitsushima T, Koike K. Pulse-wave velocity, the ankle-brachial index, and the visceral fat area are highly associated with colorectal adenoma. Dig Liver Dis. 2014;46(10):943–949. doi:doi:10.1016/j.dld.2014.05.01224953207
  • Kim J, Lee JY, Ham NS, et al. Association between carotid ultrasonography findings and colorectal adenoma in asymptomatic adults. Dig Dis Sci. 2019. doi:doi:10.1007/s10620-019-05899-7
  • Kim H, Cho YJ, Kim YA, Gwak SG. Association between colorectal adenoma and carotid atherosclerosis in Korean adults. Int J Environ Res Public Health. 2018;15(12):12. doi:doi:10.3390/ijerph15122762
  • Yun KE, Chang Y, Rampal S, et al. Coexistence of colorectal adenomas and coronary calcification in asymptomatic men and women. J Clin Gastroenterol. 2018;52(6):508–514. doi:doi:10.1097/MCG.000000000000082428471937
  • Choi SH, Kang HY, Choi SY, et al. Colorectal adenoma is associated with coronary artery calcification in a Korean population. Atherosclerosis. 2015;242(2):515–520. doi:doi:10.1016/j.atherosclerosis.2015.08.00426298744
  • Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123(5):551–565. doi:doi:10.1161/CIRCULATIONAHA.109.91256821300963
  • Higgins JPT GS, ed. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration; 2011.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:7. doi:doi:10.1371/journal.pmed.1000097
  • Whiting PF, Rutjes AWS, Westwood ME, et al. Quadas-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:doi:10.7326/0003-4819-155-8-201110180-0000922007046
  • Cha JM, Lee J, Joo KR, Shin HP, Park JJ, Cho BH. May abnormal carotid intima-media thickness predict colorectal neoplasm? Hepatogastroenterology. 2011;58(109):1142–1147. doi:doi:10.5754/hge1054121937366
  • Yang MH, Cho J, Choi YH, Son HJ, Rhee JC, Sung J. The association between coronary artery calcification and colorectal adenoma. Hepatogastroenterology. 2013;60(123):538–542. doi:doi:10.5754/hge1270923108081
  • Kim HB, Lee YJ, Shim JY, Lee HR. The association between coronary calcification and adenomatous polyps of colon in Korean adults. Clin Res Hepatol Gastroenterol. 2014;38(5):649–654. doi:doi:10.1016/j.clinre.2014.01.00424969685
  • Lee YJ, Baik SJ, Park H, et al. The association between progression of coronary artery calcium and colorectal adenoma: A retrospective follow-up study of asymptomatic Koreans. Medicine (Baltimore). 2019;98(42):e17629. doi:doi:10.1097/MD.000000000001762931626147
  • Lee JY, Hong SN, Kim JH, et al. Risk for coronary heart disease increases risk for colorectal neoplasm. Clin Gastroenterol Hepatol. 2013;11(6):695–702. doi:doi:10.1016/j.cgh.2012.10.01723078887
  • Niederseer D, Bracher I, Stadlmayr A, et al. Association between cardiovascular risk and diabetes with colorectal neoplasia: a site-specific analysis. J Clin Med. 2018;7(12):484. doi:doi:10.3390/jcm7120484
  • Ford ES, Giles WH, Mokdad AH. The distribution of 10-Year risk for coronary heart disease among U.S. adults: findings from the national health and nutrition examination survey III. J Am Coll Cardiol. 2004;43(10):1791–1796. doi:doi:10.1016/j.jacc.2003.11.06115145101
  • Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016;133(11):1104–1114. doi:doi:10.1161/CIRCULATIONAHA.115.02040626976915
  • Giovannucci E Metabolic Syndrome, Hyperinsulinemia, and Colon Cancer: A Review 1–3.; 2007 https://academic.oup.com/ajcn/article-abstract/86/3/836S/4649613. Accessed 626, 2020.
  • Pansuria M, Xi H, Li L, Yang XF, Wang H. Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci Sch. 2012;4 S(3):916–931. doi:doi:10.2741/s308
  • Handy CE, Quispe R, Pinto X, et al. Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger. Circulation. 2018;138(7):727–734. doi:10.1161/CIRCULATIONAHA.118.03551630359131
  • Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S. ColoRectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study. J Am Board Fam Med. 2014;27(1):42–55. doi:doi:10.3122/jabfm.2014.01.13004024390885
  • Handy CE, Quispe R, Pinto X, et al. Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger. Circulation. 2018;138(7):727–734. doi:doi:10.1161/CIRCULATIONAHA.118.03551630359131
  • Jee SH, Jang Y, Oh DJ, et al. A coronary heart disease prediction model: the Korean heart study. BMJ Open. 2014;4(5):e005025. doi:doi:10.1136/bmjopen-2014-005025
  • Liu J, Hong Y, D’Agostino RB, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-provincial Cohort Study. J Am Med Assoc. 2004;291(21):2591–2599. doi:doi:10.1001/jama.291.21.2591
  • Leung JY, Lin SL, Lee RS, Lam TH, Schooling CM. Framingham risk score for predicting cardiovascular disease in older adults in Hong Kong. Hong Kong Med J. 2018;24 Suppl 4(4):8–11.
  • Barzi F, Patel A, Gu D, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007;61(2):115–121. doi:doi:10.1136/jech.2005.04484217234869
  • McClelland RL, Jorgensen NW, Budoff M, et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the mesa (multi-ethnic study of atherosclerosis) with validation in the hnr (heinz nixdorf recall) study and the DHS (dallas heart Study). J Am Coll Cardiol. 2015;66(15):1643–1653. doi:doi:10.1016/j.jacc.2015.08.03526449133